Hypertension

Featured Article

Case: Severe Acute Respiratory Distress Syndrome Following HCTZ Administration

Case: Severe Acute Respiratory Distress Syndrome Following HCTZ Administration

A recent report published in The Journal of Emergency Medicine describes the case of a male patient who experienced HCTZ-induced pulmonary edema that was complicated by ARDS.

Latest Features

Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin

Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin

To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.

Blood Pressure Targets in Type 2 Diabetes: Latest Research

Blood Pressure Targets in Type 2 Diabetes: Latest Research

Experts call on healthcare providers to diligently focus on hypertension as an important comorbid condition that is strongly associated with adverse cardiovascular outcomes, including death.

Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms

Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms

Despite public perception that cannabis is "natural" and "safe," it has been implicated in many serious cardiovascular events, even in young, otherwise healthy people.

Antihypertensive Use In Pregnancy Linked With Congenital Heart Defects

Antihypertensive Use In Pregnancy Linked With Congenital Heart Defects

Antihypertensive use in the month prior to conception through the third month of pregnancy resulted in an increased risk for congenital heart defects.

HOPE-3: Hitting Pause on the Blood Pressure Gauge

HOPE-3: Hitting Pause on the Blood Pressure Gauge

How will hypertension therapy be altered by the new SPRINT and HOPE-3 trial results?

Implications of SPRINT: How Should Clinicians Respond?

Implications of SPRINT: How Should Clinicians Respond?

Clinicians, including 2 SPRINT investigators, share their perspectives on what the trial findings mean for hypertension treatment in clinical practice.

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for hypertension management during acute stroke are based on clinician experience.

Latest News

Diuretic Regimen More Effectively Reduces CV Morbidity vs Telmisartan Combinations in Hypertension With Diabetes

Diuretic Regimen More Effectively Reduces CV Morbidity vs Telmisartan Combinations in Hypertension With Diabetes

Previous studies on the suitability of diuretics for patients with hypertension and diabetes reveal inconsistencies.

Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients

Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients

Meta-analysis suggests that calcium channel blockers can be effective in preventing peripheral arterial disease in patients with hypertension.

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Combined treatment with pitavastatin and ezetimibe may be beneficial in patients with acute coronary syndrome and without hypertension for secondary prevention.

Additional Angiotensin Receptor Blocker Recalled Due to Presence of Probable Carcinogen

Additional Angiotensin Receptor Blocker Recalled Due to Presence of Probable Carcinogen

Sandoz announced a voluntary recall of 1 lot of Losartan Potassium and Hydrochlorothiazide Tablets 100mg/25mg due to trace amounts of NDEA found in the API losartan.

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

Does Antihypertensive Therapy Reduce CVD Risk in Low-Risk Patients With Mild Hypertension?

Treatment of low-risk patients presenting with mild hypertension with antihypertensive medication should be done with caution.

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity

The impurity was identified following laboratory testing conducted by the FDA; this is the first non-valsartan product that the Agency has found to contain NDEA.

Commonly Prescribed Antihypertensives Linked to Increased Lung Cancer Risk

Commonly Prescribed Antihypertensives Linked to Increased Lung Cancer Risk

To investigate the association between this commonly used antihypertensive class and lung cancer, researchers conducted a population based cohort study involving 992,061 patients from the United Kingdom Clinical Practice Research Datalink.

Disagreements in Blood Pressure Guidelines Lead to Physician, Patient Confusion

Disagreements in Blood Pressure Guidelines Lead to Physician, Patient Confusion

Discord among international, organizational blood pressure guidelines have led to confusion between physicians and patients alike.

Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions

Modifiable CV Risk Factors Within Healthy Range Indicative of CV Morphology, White Matter Lesions

In multivariable models, associations were observed between cardiovascular risk factors and cerebrovascular morphology, as well as white matter hyperintensity count.

β-Blockers in Early Pregnancy Not Linked to Cardiac Malformation Risk

β-Blockers in Early Pregnancy Not Linked to Cardiac Malformation Risk

The use of β-blockers in the first trimester of pregnancy may not greatly increase the risk for major congenital malformations in offspring.

Sign Up for Free e-Newsletters